CliffBio
small molecule

IMMPHENTIV

PHENYLEPHRINE HYDROCHLORIDE

Loss of exclusivitySeptember 2036latest FDA-listed patent expiry
CompanyHikma →See this company's full patent-cliff portfolio

Drug detail

Brand nameIMMPHENTIV
Active ingredientPHENYLEPHRINE HYDROCHLORIDE
Strength0.5MG/5ML (0.1MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMarch 2023
Marketing statusRX

Listed patents

PatentExpiresType
11213480September 2036product
12257342September 2036product
11471400August 2036product

More from Hikma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

IMMPHENTIV patent cliff — loss of exclusivity September 2036 | CliffBio